[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337814-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-337814-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","chemical-conjugation-mitigates-immunotoxicity-of-chemotherapy-via-reducing-receptor-mediated-drug-leakage-from-lipid-nanoparticles","Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles","","Immunotoxicity limits chemotherapy effectiveness in cancer therapy. This study engineered two maytansine (DM1)-loaded synthetic high-density lipoprotein variants, using either physically entrapped (ED-sHDL) or chemically conjugated (CD-sHDL) drug loading. CD-sHDL accumulated less in tumor-draining lymph nodes and femur, reducing toxicity to myeloid cells by avoiding SR-B1-mediated DM1 transport into granulocyte-monocyte progenitors and dendritic cells. In mice, CD-sHDL increased lymphocyte density in tumors, DLNs, and blood, improving colon cancer efficacy and immune memory. Conjugated-DM1 liposomes (CD-Lipo) also showed lower immunotoxicity after apolipoprotein opsonization, underscoring how loading patterns shape nanomedicine fate and activity.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/chemical-conjugation-mitigates-immunotoxicity-of-chemotherapy-via-reducing-receptor-mediated-drug-leakage-from-lipid-nanoparticles/337814/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/chemical-conjugation-mitigates-immunotoxicity-of-chemotherapy-via-reducing-receptor-mediated-drug-leakage-from-lipid-nanoparticles/337814.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in chemotherapy for cancer therapy?","Question",{"text":63,"@type":64},"Immunotoxicity remains a major hindrance to chemotherapy, impairing immune cells and limiting subsequent immunotherapy responses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do CD-sHDL and ED-sHDL differ in drug loading?",{"text":68,"@type":64},"CD-sHDL uses chemically conjugated DM1, while ED-sHDL uses physically entrapped DM1 within synthetic high-density lipoproteins.",{"name":70,"@type":61,"acceptedAnswer":71},"Why does chemical conjugation reduce immunotoxicity compared with physical entrapment?",{"text":72,"@type":64},"CD-sHDL avoids scavenger receptor class B type 1 (SR-B1)-mediated DM1 transport into granulocyte-monocyte progenitors and dendritic cells, leading to less accumulation in DLNs and femur and lower myeloid toxicity.",{"name":74,"@type":61,"acceptedAnswer":75},"How does the study support the role of loading patterns in nanomedicine activity?",{"text":76,"@type":64},"Higher lymphocyte densities and better efficacy/immune memory were observed with CD-sHDL, and conjugated-DM1 liposomes (CD-Lipo) showed reduced immunotoxicity after apolipoprotein opsonization via the same mechanism.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},337814,1791099613,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":112,"preview_page_count":33,"preview_urls":149},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","HEALTH AND MEDICINE  \nChemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles  \nChao Zheng1,2,3, Wen Zhang1,3, Xiang Gong1,3, Fengqin Xiong1,3, Linyang Jiang1, Lingli Zhou1, Yuan Zhang4, Helen He Zhu5, Hao Wang3*, Yaping Li1,6,7,8*, Pengcheng Zhang1,9*  \nImmunotoxicity remains a major hindrance to chemotherapy in cancer therapy. Nanocarriers may alleviate the immunotoxicity, but the optimal design remains unclear. Here, we created two variants of maytansine (DM1)–loaded synthetic high-density lipoproteins (D-sHDL) with either physically entrapped (ED-sHDL) or chemically conjugated (CD-sHDL) DM1. We found that CD-sHDL showed less accumulation in the tumor draining lymph nodes (DLNs) and femur, resulting in a lower toxicity against myeloid cells than ED-sHDL via avoiding scavenger receptor class B type 1 (SR-B1)–mediated DM1 transportation into the granulocyte-monocyte progenitors and dendritic cells. Therefore, higher densities of lymphocytes in the tumors, DLNs, and blood were recorded in mice receiving CD-sHDL, leading to a better efficacy and immune memory of CD-sHDL against colon cancer. Furthermore, liposomes with conjugated DM1 (CD-Lipo) showed lower immunotoxicity than those with entrapped drug (ED-Lipo) through the same mechanism after apolipoprotein opsonization. Our findings highlight the critical role of drug loading patterns in dictating the biological fate and activity of nanomedicine.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nChemotherapy is an effective treatment of cancer in the clinic. The long-term antitumor efficacy of chemotherapy is associated with its activity to prime antitumor immunity (1–3) . For instance, chemotherapeutic agents are able to trigger immunogenic cell death (ICD) of cancer cells (4–7), stimulate effector cells (1, 8, 9), and modulate immunosuppressive microenvironment (10–13) . However, chemotherapy can also impair the proliferation and cytokine secretion of immune cells (14–16) and even induce lymphodepletion under intensive treatments (17). These side effects usually lead to treatment discontinuation and a low response rate of subsequent immunotherapy (18), which limits the potential of chemotherapy.  \nTo reduce the adverse reactions of chemotherapeutic agents, nanoparticles that can modify the biodistribution of the drugs have been developed, some of which are in clinical use such as liposomaldoxorubicin and abraxane (19–21) . The potential of combinatorial nanoparticle-based chemotherapy and immunotherapy is recently under intensive investigation (22–25) . Most nanoparticles are constructed with synthetic materials such as synthetic lipids because of their well-defined and controllable properties. Given their exogenous  \n1State Key laboratory of drug Research and center of Pharmaceutics, Shanghai institute of Materia Medica, chinese Academy of Sciences, Shanghai 201203, china. 2department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, china. 3china State institute of Pharmaceutical industry, Shanghai 201203, china. 4department of Pulmonary and critical care Medicine, Shanghai Pulmonary hospital, tongji University School of Medicine, Shanghai 200433, china. 5State Key laboratory of Oncogenes and Related Genes, Renji-Med-X Stem cell Research center, department of Urology, Ren Ji hospital, School of Medicine and School of Biomedical engineering, Shanghai Jiao tong University, Shanghai 200127, china. 6Yantai Key laboratory of nanomedicine and Advanced Preparations, Yantai institute of Materia Medica, Yantai 264000, china. 7School of Pharmacy, University of chinese Academy of Sciences, Beijing 100049, china. 8Shandong laboratory of Yantai drug discovery, Bohai","cbCaijsYm3g15dwT","https://ap.wps.com/l/cbCaijsYm3g15dwT","pdf",7687903,16,"English","# Introduction\n## Chemotherapy’s immunological effects and limitations\n## Nanoparticles to modify drug biodistribution\n## Protein corona and receptor-mediated transport\n## Apolipoproteins and SR-B1 relevance","[{\"question\":\"What problem does the study address in chemotherapy for cancer therapy?\",\"answer\":\"Immunotoxicity remains a major hindrance to chemotherapy, impairing immune cells and limiting subsequent immunotherapy responses.\"},{\"question\":\"How do CD-sHDL and ED-sHDL differ in drug loading?\",\"answer\":\"CD-sHDL uses chemically conjugated DM1, while ED-sHDL uses physically entrapped DM1 within synthetic high-density lipoproteins.\"},{\"question\":\"Why does chemical conjugation reduce immunotoxicity compared with physical entrapment?\",\"answer\":\"CD-sHDL avoids scavenger receptor class B type 1 (SR-B1)-mediated DM1 transport into granulocyte-monocyte progenitors and dendritic cells, leading to less accumulation in DLNs and femur and lower myeloid toxicity.\"},{\"question\":\"How does the study support the role of loading patterns in nanomedicine activity?\",\"answer\":\"Higher lymphocyte densities and better efficacy/immune memory were observed with CD-sHDL, and conjugated-DM1 liposomes (CD-Lipo) showed reduced immunotoxicity after apolipoprotein opsonization via the same mechanism.\"}]","Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles | PDF",1790020781,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25fa22fde6481ab7a78c109c98e06e02.webp",983,1250,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/986013d061049b611e163d2c63b6c5b7.webp",982,1249,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6452c63da85a64b1c77bb72132a1150d.webp",981,1248,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d74393c6a9ae3403fd94ca7b3da1b725.webp",980,1247]